These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

341 related items for PubMed ID: 9512681

  • 1. [Targeted chemotherapy of hepatocellular carcinoma with SMANCS/Lipiodol--how to use SMANCS/Lipiodol].
    Konno T, Tabaru K, Isogai M, Nagamitsu A, Oda T.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():10-8. PubMed ID: 9512681
    [Abstract] [Full Text] [Related]

  • 2. [Evaluation of transcatheter hepatic segmental or subsegmental infusion of SMANCS for treatment of hepatocellular carcinoma].
    Inoue Y, Tomoda K, Oi H, Nakamura H.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():56-63. PubMed ID: 9512689
    [Abstract] [Full Text] [Related]

  • 3. [Arterial infusion chemotherapy with SMANCS-Lipiodol for multiple hepatocellular carcinoma].
    Takizawa K, Honda M, Obuchi M, Matsuoka S, Shima H, Uchiyama K, Hasebe S, Doai K, Satoh S, Kuniyasu Y.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():24-9. PubMed ID: 9512683
    [Abstract] [Full Text] [Related]

  • 4. [Significance of arterial infusion of SMANCS-dissolved Lipiodol in therapeutic strategies for hepatocellular carcinoma].
    Jin-no K.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():90-8. PubMed ID: 9512695
    [Abstract] [Full Text] [Related]

  • 5. [Styrene maleic acid neocarzinostatin-transcatheter embolization for hepatocellular carcinoma--third report].
    Hasegawa I, Hirashima N.
    Gan To Kagaku Ryoho; 2002 Feb; 29(2):253-9. PubMed ID: 11865632
    [Abstract] [Full Text] [Related]

  • 6. [Arterial infusion chemotherapy with SMAN CS-Lipiodol for hepatocellular carcinoma evaluation of infusion method].
    Takizawa K, Obuchi M, Honda M, Matsuoka S, Shima H, Uchiyama K, Hasebe S, Doai K, Satoh S, Kuniyasu Y.
    Gan To Kagaku Ryoho; 1997 Nov; 24(14):2117-22. PubMed ID: 9388522
    [Abstract] [Full Text] [Related]

  • 7. [Two cases of long-term survival with hepatocellular carcinoma following targeting therapy with SMANCS/lipiodol].
    Inoue Y, Nakamura H.
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):99-101. PubMed ID: 8546478
    [Abstract] [Full Text] [Related]

  • 8. [Repeated arterial infusion of zinostatin stimalamer using port for advanced hepatocellular carcinoma].
    Yoshikawa M, Ebara M, Fukuda H, Sugiura N, Saisho H.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():30-3. PubMed ID: 9512684
    [Abstract] [Full Text] [Related]

  • 9. [Combination of transcatheter arterial infusion of SMANCS and embolization (SMANCS-TAE) for hepatocellular carcinoma].
    Hirashima N.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():125-32. PubMed ID: 9512700
    [Abstract] [Full Text] [Related]

  • 10. [Arterial infusion of SMANCS-Lipiodol for advanced hepatocellular carcinoma].
    Miura K, Nakao N, Yoshimoto A, Yamano T, Inoue J, Takayasu Y.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():51-5. PubMed ID: 9512688
    [Abstract] [Full Text] [Related]

  • 11. [Targeted chemotherapy of hepatocellular carcinoma using Lipiodol as a carrier].
    Konno T, Oda T, Nagamitsu A, Tabaru K, Yamashita R, Kai Y.
    Gan To Kagaku Ryoho; 1996 Sep; 23(11):1392-9. PubMed ID: 8854762
    [Abstract] [Full Text] [Related]

  • 12. [Subsegmental transcatheter hepatic arterial embolization under balloon occlusion of the corresponding hepatic vein with SMANCS].
    Shibata H, Sogabe M, Tsutsui A, Yokoi T, Morimoto M, Fukuda T, Hayashi S, Muguruma N, Ohkita Y, Okahisa T, Okamura S, Ito S.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():133-40. PubMed ID: 9512701
    [Abstract] [Full Text] [Related]

  • 13. [Results of SMANCS/Lipiodol injection therapy for multiple intrahepatic recurrence of hepatocellular carcinoma].
    Nakaba H, Hashimoto T, Sunada S, Akamatsu D, Ito A, Teramoto S, Ohara S, Katayama S.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():46-50. PubMed ID: 9512687
    [Abstract] [Full Text] [Related]

  • 14. [A case of hepatocellular carcinoma with tumor thrombus in the right atrium successfully treated by arterial administration of lipiodol-SMANCS].
    Yamada K, Sato T, Yamada A, Tanaka S, Fujii S, Matuo R, Murata K, Manabe T, Oda J.
    Gan To Kagaku Ryoho; 1999 Feb; 26(3):361-4. PubMed ID: 10065101
    [Abstract] [Full Text] [Related]

  • 15. [Treatment of hepatocellular carcinoma by segmental SMANCS Lipiodol-TAE].
    Hayashi T, Uchida H, Matsuo N, Sakaguchi H, Anai H, Tanaka T, Yamamoto T, Ooue S, Yoshioka T, Makutani S, Oishi H.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():116-24. PubMed ID: 9512699
    [Abstract] [Full Text] [Related]

  • 16. [Targeting cancer chemotherapy using lipiodol as a carrier of anticancer drugs for hepatocellular carcinoma].
    Konno T, Maeda H.
    Gan To Kagaku Ryoho; 1988 Apr; 15(4 Pt 2-1):1043-50. PubMed ID: 2839112
    [Abstract] [Full Text] [Related]

  • 17. [Our initial experience with SMANCS in TAE for liver cancer].
    Fujita M, Inoue E, Kuroda C, Kasugai H, Sasaki Y, Nakano H, Imaoka S.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():105-8. PubMed ID: 9512697
    [Abstract] [Full Text] [Related]

  • 18. [Comparison of therapeutic effects of SMANCS (+TAE) and Non-SMANCS/LpTAE].
    Nabeshima M, Ochi J, Hikita H, Nishikawa H, Ohara T, Torii A, Fujita S, Takeda J, Miura K.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():99-104. PubMed ID: 9512696
    [Abstract] [Full Text] [Related]

  • 19. [Effect of arterial administration of a high molecular weight anti-tumor agent styrene maleic acid neocarzinostatin for multiple small liver cancer].
    Ikeda K, Saitoh S, Kumada H.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():19-23. PubMed ID: 9512682
    [Abstract] [Full Text] [Related]

  • 20. [Outcome of TAE for hepatocellular carcinoma: comparative study of SMANCS-TAE and non-SMANCS/LpTAE].
    Itsubo M, Koike K, Toda G.
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():84-9. PubMed ID: 9512694
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.